Aie luminogens for visualization and treatment of cancer
US10935552B2 · kind B2 · utility
0Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 24, 2016 |
| Grant date | Mar 2, 2021 |
| Priority date | — |
| Expiry date | Jan 30, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC09K2211/1029
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present subject matter relates to ATE luminogens for visualization and treatment of cancer, particularly AIE luminogenic probes for cancer cell visualization and discrimination, lysosome-targeting AIEgens for imaging and autophagy visualization, highly fluorescent AIE-active theranostic agents for monitoring drug distribution and having anti-tumor activity to specific cancer cells, probes comprising AIE luminogens for cancer cell imaging and staining, AIE luminogens having clusteroluminogenic features and applications thereof, and methods of preparing thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.